Abstract: The present invention relates to substituted 1,2-ethylenediamines of general formula (I) wherein the groups R1 to R15, A, B, L, i as well as X1—X4 are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.

Abstract: The invention relates to a light emitting system (1) for surfaces (2) of floor bottoms, walls or similar surfaces (2) of buildings for indoor or outdoor applications, in particular walkable or drivable surfaces (2), whereas the system comprises a laminar and plane base floor material (3) for flooring the surface (2), featuring a top surface (4) characterised in that on said top surface (4) of said base floor material (3) is layered a light guiding structure (5) for propagating light, which is coupled into said structure (5), whereas said structure (5) features an emission surface (6), arranged coplanar to the top surface (4) of said base floor material (3) for emitting the light.

Abstract: The present invention relates to substituted 1,2-ethylenediamines of general formula (I) wherein the groups R1 to R15, A, B, L, i as well as X1-X4 are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.

Abstract: A tunable radiation emitting semiconductor device includes at least one elongated structure at least partially fabricated from one or more semiconductor materials exhibiting a bandgap characteristic including one or more energy transitions whose energies correspond to photon energies of light radiation. The structure is operable to emit light radiation in response to a current flow therethrough. Moreover, the elongated structure is fabricated to be sufficiently narrow for quantum confinement of charge carriers associated with the current flow to occur therein. Furthermore, the structure further includes an electrode arrangement for applying an electric field to the elongated structure for causing bending of its bandgap characteristic for modulating a wavelength of the light radiation emitted in operation from the structure in response to the current flow therethrough.

Abstract: The present invention relates to a device for simultaneous simulation of a symmetrical and an asymmetrical impedance of an asynchronous machine. The device has three subcircuits for simulating the three phases of the asynchronous machine. Each subcircuit preferably comprises a series connection of a main inductance, a leakage inductance and a resistor between the input terminal and the output terminal, which are connected in parallel to ground across a capacitor and a resistor in each case. A magnetic coupling is implemented or the effect of a magnetic coupling is simulated for the main inductances of the subcircuits. This device can be used to advantage instead of the asynchronous machine in calibration of EMC filters.

Abstract: New compounds of formula 1 are provided which by virtue of their pharmaceutical activity as PI3-kinase modulators may be used in the therapeutic field for the treatment of inflammatory or allergic diseases. Examples of these include inflammatory and allergic respiratory complaints, inflammatory diseases of the gastro-intestinal tract and motor apparatus, inflammatory and allergic skin diseases, inflammatory eye diseases, diseases of the nasal mucosa, inflammatory or allergic conditions involving autoimmune reactions or inflammations of the kidney.

Abstract: The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1 to R13, A, B, L, and i are defined as indicated in the description and the claims, as well as the use thereof for treating Alzheimer's disease (AD) and similar diseases.

Abstract: The invention relates to a compound of the formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and R8 are defined as in the specification and claims and to its use for treating or preventing Alzheimer's disease and other similar diseases.

Abstract: According to an example embodiment there is a semiconductor component, which is arranged in a semiconductor body, with at least one source zone and with at least one drain zone which in each case is a first conductivity type, with at least one body zone of a second conductivity type arranged in each case between source zone and drain zone, and with at least one gate electrode insulated with an insulating layer relative to the semiconductor body. The insulating layer is a consolidated, preferably sintered, layer containing quantum dots.

Abstract: There is described a tunable radiation emitting semiconductor device (50) comprising at least one elongated structure (120) at least partially fabricated from one or more semiconductor materials exhibiting a bandgap characteristic including one or more energy transitions whose energies correspond to photon energies of light radiation. The at least one structure (120) is thereby operable to emit light radiation therefrom in response to a current flow therethrough. Moreover, the at least one elongated structure (120) is fabricated to be sufficiently narrow for quantum confinement of charge carriers associated with the current flow to occur therein.

Abstract: The invention relates to an organic electroluminescent light source having at least one substrate (5) and a plurality of layers arranged on the substrate (5), said layers comprising at least two electrodes of which at least one electrode is transparent and one acts as an anode and one as a cathode, at least one organic electroluminescent layer that is arranged between the electrodes, the organic electroluminescent layer having a plurality of regions (6, 7) that emit either blue light or green light, and at least one phosphor layer (8) that is arranged in the beam path of the light leaving the organic electroluminescent light source and that partly covers the electroluminescent layer.

Abstract: When decoding an OFDM signal, frame and frequency synchronisation is necessary. The invention shows a method enabling a high accuracy for frame and frequency synchronization, which leads to a very low error rate in comparison to prior art.

Abstract: The present invention provides bradykinin-B1 antagonists of the formula in which A, Ar, G, Q, R1 and R4 are as defined in claim 1, their enantiomers, their diastereomers, their mixtures and their salts, in particular their physiologically acceptable salts with organic or inorganic acids or bases having useful properties, their preparation, medicaments comprising the pharmacologically effective compounds, their preparation and their use.

Abstract: The invention relates to a compound of the formula (I) wherein R1, R2, R3, R4, R5, R6, R7 and R8 are defined as in the specification and claims and to its use for treating or preventing Alzheimer's disease and other similar diseases.

Abstract: The invention applies techniques for image reconstruction from X-ray diffraction patterns on the three-dimensional imaging of defects in EUVL multilayer films. The reconstructed image gives information about the out-of-plane position and the diffraction strength of the defect. The positional information can be used to select the correct defect repair technique. This invention enables the fabrication of defect-free (since repaired) X-ray Mo—Si multilayer mirrors. Repairing Mo—Si multilayer-film defects on mask blanks is a key for the commercial success of EUVL. It is known that particles are added to the Mo—Si multilayer film during the fabrication process. There is a large effort to reduce this contamination, but results are not sufficient, and defects continue to be a major mask yield limiter. All suggested repair strategies need to know the out-of-plane position of the defects in the multilayer.

Abstract: A semiconductor device, which is arranged in a semiconductor body (1), and which comprises at least one source region (4) and at least one drain region (5), each being of the first conductivity type, and at least one body (8) of the second conductivity type, arranged between source region (4) and drain region (5), and at least one gate electrode (10) which is isolated with respect to the semiconductor body (1) via an isolation layer (9). Said isolation layer (9) comprises polarizable particles, which are composed of a nanoparticulate isolating core and a sheath of polarizable anions or polarizable cations. The isolation layer (9) exhibits a high dielectric constant ?.

Abstract: The present invention relates to substituted 1,2-ethylenediamines of general formula (I) wherein the groups R1 to R15, A, B, L, i as well as X1-X4 are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.

Abstract: The invention relates to a bicyclic oligopeptide or ester thereof having the capability to inhibit the glucagon receptor, comprised of: (a) a first cyclic group, which comprises at least one cysteine group and is formed by an amide bonding of the N-terminal amino acid with the second carboxylate group of a diacid amino acid, and (b) a second cyclic group which is formed by an amide bonding of an amino acid with the ?-carboxylate group of said diacid amino acid, and by a disulfide bonding of the C-terminal cysteine and a cysteine group within the first cyclic group (a); and to the use of such bicyclic oligopeptides for the preparation of a medicament for the treatment or prevention of diseases, in which glucagon receptors are involved.

Abstract: The invention relates to a compound of the formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are defined as in the specification and claims and to its use for treating or preventing Alzheimer's disease and other similar diseases.

Abstract: Pharmaceutical compositions in the form of ready-to-use preparations of gemcitabine in aqueous solutions in a glass containers having specified dimensional relationships demonstrate long shelf life over a wide range of solution pH values. The ratio of the surface area of the container wetted by the solution to the volume of the solution, expressed in cm2 to cm3, is less than 3.4.